DOI QR코드

DOI QR Code

Aldosterone-Producing Adrenocortical Carcinoma without Hypertension

  • Song, Min-Soo (Department of Internal Medicine, Soonchunhyang University College of Medicine) ;
  • Seo, Sung-Woo (Department of Internal Medicine, Soonchunhyang University College of Medicine) ;
  • Bae, Sang-Byung (Department of Internal Medicine, Soonchunhyang University College of Medicine) ;
  • Kim, Yeo-Joo (Department of Internal Medicine, Soonchunhyang University College of Medicine) ;
  • Kim, Sang-Jin (Department of Internal Medicine, Soonchunhyang University College of Medicine)
  • Published : 2012.06.01

Abstract

Although adrenocortical tumors are common, adrenocortical carcinomas are rare. Moreover, aldosterone-producing adrenocortical carcinomas without hypertension are exceedingly rare, with only two previously reported cases.

Keywords

References

  1. Ganguly A. Primary aldosteronism. N Engl J Med 1998;339:1828-1834. https://doi.org/10.1056/NEJM199812173392507
  2. Young WF. Primary aldosteronism: renaissance of a syndrome. Clin Endocrinol (Oxf) 2007;66:607-618. https://doi.org/10.1111/j.1365-2265.2007.02775.x
  3. Seccia TM, Fassina A, Nussdorfer GG, Pessina AC, Rossi GP. Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn's syndrome with an ominous clinical course. Endocr Relat Cancer 2005;12:149-159. https://doi.org/10.1677/erc.1.00867
  4. Muthusethupathi MA, Vimala A, Jayakumar M, Rajendran S. Normotensive primary aldosteronism due to adrenocortical carcinoma. Nephron 1998;79:247-248. https://doi.org/10.1159/000045045
  5. Yamazaki H, Abe Y, Katoh Y, et al. Establishment of an adrenocortical carcinoma xenograft with normotensive hyperaldosteronism in vivo. APMIS 1998;106:1056-1060. https://doi.org/10.1111/j.1699-0463.1998.tb00258.x
  6. Allolio B, Fassnacht M. Clinical review: Adrenocor tical carcinoma: clinical update. J Clin Endocrinol Metab 2006;91:2027-2037. https://doi.org/10.1210/jc.2005-2639
  7. Vantyghem MC, Ronci N, Provost F, et al. Aldosterone-producing adenoma without hypertension: a report of two cases. Eur J Endocrinol 1999;141:279-285. https://doi.org/10.1530/eje.0.1410279
  8. Schwartz GL, Turner ST. Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. Clin Chem 2005;51:386-394. https://doi.org/10.1373/clinchem.2004.041780
  9. Williams JS, Williams GH, Raji A, et al. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens 2006;20:129-136. https://doi.org/10.1038/sj.jhh.1001948

Cited by

  1. Aldosterone-Secreting Adrenal Cortical Carcinoma. A Case Report and Review of the Literature vol.25, pp.3, 2012, https://doi.org/10.1007/s12022-014-9307-x
  2. 5th International ACC Symposium: Old Syndromes with New Biomarkers and New Therapies with Old Medications vol.7, pp.1, 2012, https://doi.org/10.1007/s12672-015-0247-9
  3. Le corticosurrénalome: une cause exceptionnelle d’hyperaldostéronisme primaire vol.31, pp.None, 2018, https://doi.org/10.11604/pamj.2018.31.60.16973